maximum androgen ablation
maximum androgen ablation
A form of hormonal therapy for prostate cancer using combined therapy—e.g., gonadotropin-releasing hormone agonist plus flutamide—to decrease effects of gonadal and adrenal androgens.MAA was said to provide a ± 6 month survival advantage, but it is no longer in active use.